Oxbow Advisors, LLC Astrazeneca PLC Transaction History
Oxbow Advisors, LLC
- $883 Million
- Q3 2025
A detailed history of Oxbow Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Oxbow Advisors, LLC holds 77,594 shares of AZN stock, worth $6.94 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
77,594
Previous 39,551
96.19%
Holding current value
$6.94 Million
Previous $2.76 Million
115.45%
% of portfolio
0.67%
Previous 0.36%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...